Sentinel lymph node biopsy for breast cancer after neoadjuvant chemotherapy: Influence of nodal status before treatment;Lymphadénectomie axillaire sentinelle après chimiothérapie néoadjuvante pour cancer du sein: Influence du statut ganglionnaire initial

Bulletin du Cancer

Volumn 93, Issue 4, 2006, Pages 415-419

  Le Bouëdec, Guillaume ^a   Geissler, Benjamin ^a   Gimbergues, Pierre ^a   Cachin, Florent ^a   Penault Llorca, Frédérique ^a   Kwiatkowski, Fabrice ^a   Dauplat, Jacques ^a   Maublant, Jean ^a  

^a Centre Regional de Lutte Contre le Cancer Jean Perrin   (France)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Sentinel lymph node

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; INVASIVE CARCINOMA; ISOTOPE LABELING; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 33646708057     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-40.
2. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-420.
3. Rodier JF. Le repérage du ganglion sentinelle par le chirurgien. Bull Cancer 2002; 89: 840-4.
4. Delahaye S, Benamor M, Nos C, Vincent-Salomon A, El Khoury C, Doridot V, et al. Le ganglion sentinelle en routine dans le cancer du sein: expérience de l'Institut Curie. Bull Cancer 2004; 91: 641-7.
5. Bedrosian I, Reynolds C, Mick R, Callans LS, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000; 88: 2540-5.
6. Olson Jr. JA, Fey J, Winawer J, I Borgen P, Cody III HS, Van Zee KJ, et al. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 2000; 191: 593-9.
7. Bobin JY, Zinzindohoue C, Faure Virelizier C, Joulai A, Khaled M. La chirurgie conservatrice des cancers du sein T2 > 3 cm, T3 N0 Nl M0 après chimiothérapie d'induction. Bull Cancer 2001; 88: 175-80.
8. Trocha SD, Guiliano AE. Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer. Surg Oncol 2003; 12: 271-6.
9. Schrenk P, Huchreiner G, Fridrik M. Sentinel mode biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer. Breast J 2003; 9: 282-7.
10. Jones JL, Zabicki K, Christian RL, Gadd MA, Hugues KS, Lesnikoski BA, et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg 2005; 190: 517-20.
11. Leidenius MHK, Krogerus LA, Toivonen TS, von Smitten KAJ. Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours. Eur J Surg Oncol 2005; 31: 364-8.
12. Ollila DW, Neuman HB, Sartor C, Carey LA, Klaubert-Demore N. Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers. Am J Surg 2005; 190: 371-5.
13. Nason KS, Anderson BO, Byrd DR, Dunnwald LK, Eary JF, Mankoff DA, et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000; 89: 2187-94.
14. Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000; 18: 3480-6.
15. Fernandez A, Cortes M, Benito E, Azpeitia D, Prieto L, Moreno A, et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 2001; 22: 361-6.
16. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002; 9: 235-42.
17. Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 2001; 182: 312-5.
18. Schwartz GF, Meltzer AJ. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 2003; 9: 374-9.
19. Lang JE, Esserman LJ, Ewing CA, Rugo HS, Lane KT, Leong SP, et al. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg 2004; 199: 856-62.
20. Shimazu K, Tamaki Y, Taguchi T, Akasawa K, Inoue T, Noguchi S. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer 2004; 100: 2555-61.
21. Maublant J, Cachin F, Mestas D, Geissler B. Le repérage du ganglion sentinelle en médecine nucléaire. Bull Cancer 2002; 89: 671-80.
22. Piato JR, Barros AC, Pincerato KM. Sentinel node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 2003; 29: 118-20.
23. Vigàrio A, Sapienza MT, Sampaio AP, Piato JR, Barros N, Barros A, et al. Primary chemotherapy effect in sentinel node detection in breast cancer. Clin Nucl Med 2003; 28: 553-7.
24. Kang SH, Kim SK, Kwon Y, Kang HS, Rang JH, Ro J, et al. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg 2004; 28: 1019-24.
25. Haid A, Tausch C, Lang A, Lutz J, Fritzsche H, Peschina W, et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001; 92: 1080-4.
26. Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 2002; 8: 97-100.
27. Miller AR, Thomason VE, Yeh IT, Alrahwan A, Sharkey FE, Stauffer J, et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol 2002; 9: 243-7.
28. Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2002; 184: 315-7.
29. Balch GC, Mithani SK, Richards KR, Beauchamps D, Kelley M. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 2003; 10: 616-21.
30. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Surg Oncol 2003; 84: 63-7.
31. Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, et al. Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol 1999; 6: 762-7.
32. Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2005; 23: 2694-702.
33. Curé H, Amat S, Penault-Llorca F, Le Bouëdec G, Ferrière JP, Mouret-Reynier MA, et al. Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy. Breast Cancer Res Treat 2002; 76: 37-45.
34. Pierga JY, Mouret E, Diéras V, Laurence V, Beuzeboc P, Dorval T, et al. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. Br J Cancer 2000; 83: 1480-7.
35. Giard S, Chauvet MP, Houpeau JL, Baranzelli MC, Carpentier P, Fournier C, et al. Le ganglion sentinelle sans curage systématique dans le cancer du sein: bilan d'une expérience de 1000 interventions. Gynecol Obstet Fertil 2005; 33: 213-9.
36. Salvat J, Margonari H, Hardelin D. Choc anaphylactique au « bleu patenté » lors de la recherche du ganglion sentinelle. J Gynecol Obstet Biol Reprod (Paris) 1999; 28: 393-4.
37. Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK. Allergic reactions to isosulfan blue during sentinel node biopsy: a common event. Surgery 2001; 130: 439-42.
38. Mullan MH, Deacock SJ, Quiney NF, Kissin MW. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 2001; 27: 218-9.